v3.25.2
Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Consolidated Statements of Comprehensive Income Loss [Abstract]    
Revenue $ 2,265 $ 5,356
Cost of Revenue 1,452 2,706
Gross profit 813 2,650
Research and development expenses 384 259
Selling and marketing expenses 539 699
General and administrative expenses 1,499 1,425
Operating Profit (Loss) (1,609) 267
Listing expenses 879
Finance Expenses 65 232
Finance Income 38 148
Loss before income taxes (1,636) (696)
Income taxes expenses
Net Loss for the period (1,636) (696)
Amounts that shall not be subsequently reclassified to profit and loss:    
Loss from remeasurement of defined benefit plans
Total comprehensive loss for the period $ (1,636) $ (696)
Basic loss per share (in Dollars per share) $ (0.2736) $ (0.1358)
Weighted average of the number of ordinary shares used to calculate basic loss per share (in Shares) 5,980,013 5,123,789
Diluted loss per share (in Dollars per share) $ (0.2736) $ (0.1358)
Weighted average of the number of ordinary shares used to calculate diluted loss per share (in Shares) 5,980,013 5,123,789